Foetal lipoprotein oxidation and preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Medicine
• Neonatology
• Biochemistry

Background:

• Preeclampsia (PE) is a pregnancy-specific multisystem disorder and a leading cause of maternal mortality.
• The etiology of PE remains unknown, but altered lipid metabolism and oxidative stress are implicated.
• Lipoproteins, including LDL and HDL, are susceptible to oxidative damage, generating harmful byproducts like malondialdehyde (MDA).

Purpose of the Study:

• To review the impact of oxidized low-density lipoprotein (oxLDL) and high-density lipoprotein (HDL) in neonates born to mothers with preeclampsia.
• To investigate how these lipoprotein alterations predispose neonates to adult-onset diseases.

Main Methods:

• Literature review analyzing existing information on lipoprotein oxidation in preeclampsia and its neonatal consequences.
• Focus on the role of oxidized LDL (oxLDL) in endothelial dysfunction and nitric oxide (NO) production.
• Examination of the long-term health risks for neonates exposed to the preeclamptic intrauterine environment.

Main Results:

• Oxidized LDL (oxLDL) interferes with endothelial nitric oxide synthase (eNOS) signaling, reducing vasodilation and causing endothelial dysfunction characteristic of PE.
• Severe lipid damage in PE can generate toxic products like malondialdehyde (MDA).
• Neonates of mothers with PE exhibit increased risks for cardiovascular diseases, stroke, developmental issues, and metabolic diseases later in life.

Conclusions:

• Oxidative stress and subsequent lipoprotein modification in preeclampsia pose significant risks to fetal development.
• Neonates exposed to PE in utero are predisposed to chronic diseases, including cardiovascular and metabolic disorders, in adulthood.
• Further research is needed to understand the mechanisms linking maternal PE, neonatal lipoprotein alterations, and long-term health outcomes.